4.6 Article

Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies

Journal

BJU INTERNATIONAL
Volume 105, Issue 1, Pages 16-20

Publisher

WILEY
DOI: 10.1111/j.1464-410X.2009.08706.x

Keywords

kidney neoplasms; carcinoma; renal cell; obesity; body mass index; histology

Funding

  1. The Stephen Hanson Family Fellowship
  2. NIH [T32 CA82088]
  3. Sidney Kimmel Center for Prostate and Urologic Cancers
  4. NATIONAL CANCER INSTITUTE [T32CA082088] Funding Source: NIH RePORTER

Ask authors/readers for more resources

OBJECTIVE To investigate the association between body mass index (BMI) and histology of renal cell carcinoma (RCC) in a contemporary cohort, as obesity is increasingly prevalent in the USA and might be contributing to the increasing incidence of RCC, but little is known about the relationship of obesity with the different histological subtypes of RCC. PATIENTS AND METHODS From January 2000 to December 2007 we identified 1640 patients with renal cortical tumours undergoing surgical extirpation at our institution, and who had their BMI recorded. Multivariable logistic regression models were used to test the association of BMI with RCC histology. RESULTS The median (interquartile range) BMI was 28 (25-32) kg/m2 and 38% of patients were classified as obese (BMI > 30 kg/m2). After adjusting for tumour size, age, gender, American Society of Anesthesiologists score, estimated glomerular filtration rate, hypertension, diabetes mellitus and smoking, the BMI was significantly associated with clear-cell histology; the odds ratios were 1.04 for each unit of BMI (95% confidence interval, CI, 1.02-1.06; P < 0.001) and 1.48 when comparing obese vs non-obese patients (95% CI 1.19-1.84; P < 0.001). In the subgroup of patients with RCC (excluding benign renal cortical tumours), BMI was still an independent predictor of clear-cell histology (odds ratio 1.04, 95% CI 1.02-1.06, P = 0.001). CONCLUSIONS These results suggest that BMI is an independent predictor of clear-cell histology in patients with a renal cortical tumour. While the aetiology of this phenomenon requires further study, these findings might have implications in determining a patient's risk of harbouring a clear-cell RCC and in subsequent treatment recommendations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Urology & Nephrology

Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial

Bernard H. Bochner, Guido Dalbagni, Daniel D. Sjoberg, Jonathan Silberstein, Gal E. Keren Paz, S. Machele Donat, Jonathan A. Coleman, Sheila Mathew, Andrew Vickers, Geoffrey C. Schnorr, Michael A. Feuerstein, Bruce Rapkin, Raul O. Parra, Harry W. Herr, Vincent P. Laudone

EUROPEAN UROLOGY (2015)

Article Urology & Nephrology

A Cost-effectiveness Analysis of Management of Low-risk Non-muscle-invasive Bladder Cancer Using Office-based Fulguration

Bashir Al Hussein Al Awamlh, Richard Lee, Bilal Chughtai, S. Machele Donat, Jaspreet S. Sandhu, Harry W. Herr

UROLOGY (2015)

Article Urology & Nephrology

Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer

Jennifer M. Taylor, Andrew Feifer, Caroline J. Savage, Alexandra C. Maschino, Melanie Bernstein, Harry W. Herr, S. Machele Donat

BJU INTERNATIONAL (2012)

Article Urology & Nephrology

Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer

Joshua J. Meeks, Jennifer M. Taylor, Kazuhito Matsushita, Harry W. Herr, S. Machele Donat, Bernard H. Bochner, Guido Dalbagni

BJU INTERNATIONAL (2013)

Article Urology & Nephrology

Preoperative serum albumin is associated with mortality and complications after radical cystectomy

Tullika Garg, Ling Y. Chen, Philip H. Kim, Philip T. Zhao, Harry W. Herr, S. Machele Donat

BJU INTERNATIONAL (2014)

Article Oncology

A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy

Yoshiya Yamada, Marisa A. Kollmeier, Xin Pei, Chu Cheng Kan, Gil'ad N. Cohen, Sherri M. Donat, Brett W. Cox, Michael J. Zelefsky

BRACHYTHERAPY (2014)

Meeting Abstract Oncology

Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND

Christopher Michael Tully, Bernard H. Bochner, Guido Dalbagni, Emily C. Zabor, Harry W. Herr, S. Machele Donat, Irina Ostrovnaya, Ashley Marie Regazzi, Philip H. Kim, John P. Sfakianos, Jonathan E. Rosenberg, Dean F. Bajorin

JOURNAL OF CLINICAL ONCOLOGY (2014)

Article Urology & Nephrology

Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline

Sherri M. Donat, Mireya Diaz, Jay Todd Bishoff, Jonathan A. Coleman, Philipp Dahm, Ithaar H. Derweesh, S. Duke Herrell, Susan Hilton, Eric Jonasch, Daniel W. Lin, Victor E. Reuter, Sam S. Chang

JOURNAL OF UROLOGY (2013)

Article Urology & Nephrology

Upper Tract Imaging Surveillance is not Effective in Diagnosing Upper Tract Recurrence in Patients Followed for Nonmuscle Invasive Bladder Cancer

Itay A. Sternberg, Gal E. Keren Paz, Ling Y. Chen, Harry W. Herr, Sherri M. Donat, Bernard H. Bochner, Guido Dalbagni

JOURNAL OF UROLOGY (2013)

Article Urology & Nephrology

Intravesical Gemcitabine for High Risk, Nonmuscle Invasive Bladder Cancer after Bacillus Calmette-Guerin Treatment Failure

Itay A. Sternberg, Guido Dalbagni, Ling Y. Chen, Sherri M. Donat, Bernard H. Bochner, Harry W. Herr

JOURNAL OF UROLOGY (2013)

Article Urology & Nephrology

Urinary Diversion Practice Patterns Among Certifying American Urologists

Jonathan L. Silberstein, Stephen A. Poon, Alexandra C. Maschino, William T. Lowrance, Tullika Garg, Harry W. Herr, S. Machele Donat, Guido Dalbagni, Bernard H. Bochner, Jaspreet S. Sandhu

JOURNAL OF UROLOGY (2013)

Article Urology & Nephrology

Gender Disparities in Hematuria Evaluation and Bladder Cancer Diagnosis: A Population Based Analysis

Tullika Garg, Laura C. Pinheiro, Coral L. Atoria, S. Machele Donat, Joel S. Weissman, Harry W. Herr, Elena B. Elkin

JOURNAL OF UROLOGY (2014)

Article Urology & Nephrology

Clinical Outcome of Patients with T1 Micropapillary Urothelial Carcinoma of the Bladder

Massimiliano Spaliviero, Guido Dalbagni, Bernard H. Bochner, Bing Ying Poon, Hongying Huang, Hikmat A. Al-Ahmadie, Timothy F. Donahue, Jennifer M. Taylor, Joshua J. Meeks, Daniel D. Sjoberg, S. Machele Donat, Victor E. Reuter, Harry W. Herr

JOURNAL OF UROLOGY (2014)

Article Oncology

Adherence to surveillance guidelines after radical cystectomy: A population-based analysis

Behfar Ehdaie, Coral L. Atoria, William T. Lowrance, Harry W. Herr, Bernard H. Bochner, S. Machele Donat, Guido Dalbagni, Elena B. Elkin

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)

Review Urology & Nephrology

Evaluation of Women With a Positive Urine Cytology and no Demonstrable Disease in the Urinary Tract

Sherri M. Donat, Yukio Sonoda, Hikmat Al-Ahmadie, Rajmohan Murali, Dianna L. Ng, Samuel A. Funt, Kay J. Park

Summary: Urinary cytology is crucial for evaluating gross hematuria and monitoring urothelial neoplasms. A positive urine cytology typically indicates the presence of urothelial carcinoma in the urinary tract, but it may also suggest involvement of the lower gynecologic tract or rectum in women. Guidelines for evaluating women with positive cytology and normal urinary tract are lacking. This review aims to raise clinicians' awareness of this diagnostic dilemma with case scenarios. UROLOGY 173: 10-16, 2023. (c) 2023 Elsevier Inc.

UROLOGY (2023)

No Data Available